Skip to main content
. Author manuscript; available in PMC: 2024 Mar 7.
Published in final edited form as: J Pediatr Endocrinol Metab. 2023 Nov 23;37(1):8–14. doi: 10.1515/jpem-2023-0390

Table 2:

Characteristics and serum copeptin concentrations during GH testing for the Outlier group

Sex Age
(years)
Stimulating
Agent(s)
Copeptin (pmol/L) %decrease
from 0 to
120 minutes
Anxiety
−20
minutes
0
minutes
60
minutes
90
minutes
120
minutes
Male 11.5 Arg-Clon - 62 42 39 33 47% Not Present
Male 14.5 Arg-Insulin - 471 130 140 71 85% Present
Male 15.0 Arg-Insulin - 362 65 87 48 86% Present
Female 15.7 Insulin - 202 51 40 29 86% Present
Male 7.2 Arg-L-Dopa /Carbidopa - 1361 282 355 194 86% Not Present
Male 13.5 Arg-L-Dopa /Carbidopa 158 106 126 65 67 58% Present
Female 11.9 Arg-L-Dopa /Carbidopa 71 61 33 26 28 61% Not Present
Female 9.1 Arg-L-Dopa /Carbidopa 42 40 36 39 38 9% Present

Abbreviations: Arg, arginine; Clon, clonidine